LyssnCBT for Cognitive Behavioral Therapy

Phase-Based Progress Estimates
The Penn Collaborative for CBT and Implementation Science, Philadelphia, PACognitive Behavioral Therapy+1 MoreLyssnCBT - Other
All Sexes
What conditions do you have?

Study Summary

This trial will assess a new tech-based solution to help therapists deliver evidence-based psychotherapies to people with mental illness and addiction, which could lead to better outcomes and reduce the global mental health burden.

Eligible Conditions
  • Therapies
  • Cognitive Behavioral Therapy

Treatment Effectiveness

Effectiveness Progress

1 of 3

Study Objectives

8 Primary · 0 Secondary · Reporting Duration: Immediately before weekly therapy sessions for the duration of treatment or through study completion, a maximum of 18 months

After three months of engagement with the LyssnCBT tools
Acceptability of LyssnCBT tools (Acceptability of Intervention Measure; AIM)
Month 18
Change in client anxiety symptoms (General Anxiety Disorder; GAD-7)
Change in client depression symptoms (Patient Health Questionnaire; PHQ-9)
Client drop-out/premature termination from therapeutic engagement
Phase 2; Immediately after every recorded therapy session
Change in therapist CBT fidelity as assessed by CTRS scores
Phase 2; Three months after the site moves from SAU to LyssnCBT
Appropriateness of LyssnCBT tools (Intervention Appropriateness Measure; IAM)
Feasibility of LyssnCBT tools (Feasibility of Intervention Measure; FIM)
Usability of LyssnCBT tools (System Usability Scale; SUS)

Trial Safety

Trial Design

2 Treatment Groups

1 of 2
SAU (services-as-usual)
1 of 2

Active Control

1957 Total Participants · 2 Treatment Groups

Primary Treatment: LyssnCBT · No Placebo Group · N/A

ActiveComparator Group · 1 Intervention: LyssnCBT · Intervention Types: Other
SAU (services-as-usual)NoIntervention Group · 1 Intervention: SAU (services-as-usual) · Intervention Types:

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: immediately before weekly therapy sessions for the duration of treatment or through study completion, a maximum of 18 months

Who is running the clinical trial?

University of PennsylvaniaLead Sponsor
1,876 Previous Clinical Trials
41,146,882 Total Patients Enrolled
1 Trials studying Cognitive Behavioral Therapy
2 Patients Enrolled for Cognitive Behavioral Therapy, Inc.Industry Sponsor
2 Previous Clinical Trials
500 Total Patients Enrolled
National Institute of Mental Health (NIMH)NIH
2,585 Previous Clinical Trials
1,982,811 Total Patients Enrolled
David Atkins, PhDPrincipal InvestigatorCEO, Lyssn
Torrey A Creed, PhDPrincipal InvestigatorDirector, The Penn Collaborative for CBT and Implementation Science

Eligibility Criteria

Age 18+ · All Participants · 9 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
I'm sorry, but the given screening criterion is incomplete. Could you please provide more information?
You are okay with your therapy sessions being recorded and used for research.
I'm sorry, it seems like the criterion you provided is incomplete. Can you please provide me with more information so I can accurately summarize it for you?

Frequently Asked Questions

Does this trial accept new participants?

" reports that this investigation is actively enrolling participants, having been first advertised on the 9th of March and last revised 4 days later." - Anonymous Online Contributor

Unverified Answer
Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.